Product Highlight - Nextstellis

Active ingredient: Each pink active tablet contains 3 mg drospirenone & estetrol monohydrate 15 mg equivalent to 14.2 mg estetrol.

Indications: Oral contraception.

Posology and method of administration: 1 tab for 28 consecutive days. No preceding hormonal contraceptive use in the past mth Start on day 1 of menstrual cycle, ie, 1st day of menstrual bleeding. Changing from combined hormonal contraceptives (CHC) [combined OC (COC), vag ring or transdermal patch] Start preferably on the day after the last active tab (last tab containing active substances) of previous COC, but at the latest on the day following the usual tab-free or placebo tab interval of previous COC. Vag ring or transdermal patch: Start preferably on the day of removal, but at the latest when the next application would have been due. Changing from progestogen-only method (progestogen-only pill, inj, implant) or from progestogen-releasing intrauterine system (IUS) May switch any day from progestogen-only pill. Implant or IUS: On the day of removal. Injectable: When the next inj would be due. Following 1st-trimester abortion May start immediately. Following delivery or 2nd-trimester abortion Start between day 21 & 28 after delivery or 2nd-trimester abortion.